HeartFlow Highlights Two Presentations at the 2020 American Heart Association Virtual Meeting
Summary
REDWOOD CITY, Calif.--(BUSINESS WIRE)--HeartFlow today announced two presentations at the American Heart Association (AHA) conference being held as a virtual meeting on November 13-17, 2020. Details for the presentations are as follows: Title: Consideration for CCTA With or Without CT-FFR in Patients With Chest Pain Presenter: Pamela S. Douglas, M.D., professor of research in cardiovascular diseases in the department of medicine at Duke University and director of the Multimodality Imaging Program at Duke Clinical Research Institute Date and Time: Saturday, November 14, 2020,10:51 AM – 10:59 AM CST Title: Links in the Value Chain: Where AI and Machine Learning Fit In Presenter: Geoffrey D. Rubin, M.D., chair of the department of medical imaging at the University of Arizona College of Medicine – Tucson Date and Time: Monday, November 16, 2020,11:10 AM – 11:18 AM CST “We are looking forward to these presentations by Dr. Douglas and Dr. Rubin regarding the compelling evidence for the value of coronary computed tomography angiography (CTA) as the default first diagnostic test for patients with stable chest pain,” said Campbell Rogers, M.D., FACC, Chief Medical Officer, HeartFlow. Starting with a standard coronary CTA, the HeartFlow Analysis leverages deep learning and highly trained analysts to create a digital, personalized 3D model of the heart. The HeartFlow Analysis then uses powerful computer algorithms to solve millions of complex equations to simulate blood flow and provides FFRct values along the coronary arteries. HeartFlow, Inc. is a digital health company uniquely positioned at the intersection of advanced artificial intelligence and healthcare to transform how heart disease is diagnosed and treated.